Q1: 2026-04-29 Earnings Summary
EPS of $9.47 beats by $0.57
|
Revenue of
$3.61B
(19.04% Y/Y)
beats by $122.03M
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2026 Earnings Call April 29, 2026 8:30 AM EDT
Company Participants
Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis
Leonard Schleifer - Co-Founder, President, CEO & Co-Chairman
George Yancopoulos - Co-Founder, President, Chief Scientific Officer & Co-Chairman
Marion McCourt - Executive Vice President of Commercial
Christopher Fenimore - Executive VP of Finance & CFO
Conference Call Participants
Tyler Van Buren - TD Cowen, Research Division
Chun Yu - Morgan Stanley, Research Division
Samuel Alexander Leach - Raymond James & Associates, Inc., Research Division
Cory Kasimov - Evercore ISI Institutional Equities, Research Division
Tazeen Ahmad - BofA Securities, Research Division
Carter Gould - Cantor Fitzgerald & Co., Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Alexandria Hammond - Wolfe Research, LLC
Salveen Richter - Goldman Sachs Group, Inc., Research Division
Taylor Hanley - JPMorgan Chase & Co, Research Division
David Risinger - Leerink Partners LLC, Research Division
Geoffrey Meacham - Citigroup Inc., Research Division
Brian Abrahams - RBC Capital Markets, Research Division
Presentation
Operator
Welcome to the Regeneron Pharmaceuticals First Quarter 2026 Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. [Operator Instructions] Please note this conference is being recorded.
I will now turn the call over to Ryan Crowe, Senior Vice President, Investor Relations. You may begin.
Ryan Crowe
Senior Vice President of Investor Relations & Strategic Analysis
Thank you, Kevin. Good morning, good afternoon and good evening to everyone listening around the world. Thank you for your interest in Regeneron and welcome to our first quarter 2026 earnings conference call. An archive and transcript of this call will be available on the Regeneron Investor Relations website shortly after our call concludes.
Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Board Co-Chair, Co-Founder, President and Chief Scientific Officer; Marion McCourt, Executive Vice President of Commercial; and Chris
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。